Utilization of dietary glucose in the metabolic syndrome

This review is focused on the fate of dietary glucose under conditions of chronically high energy (largely fat) intake, evolving into the metabolic syndrome. We are adapted to carbohydrate-rich diets similar to those of our ancestors. Glucose is the main energy staple, but fats are our main energy reserves. Starvation drastically reduces glucose availability, forcing the body to shift to fatty acids as main energy substrate, sparing glucose and amino acids. We are not prepared for excess dietary energy, our main defenses being decreased food intake and increased energy expenditure, largely enhanced metabolic activity and thermogenesis. High lipid availability is a powerful factor decreasing glucose and amino acid oxidation. Present-day diets are often hyperenergetic, high on lipids, with abundant protein and limited amounts of starchy carbohydrates. Dietary lipids favor their metabolic processing, saving glucose, which additionally spares amino acids. The glucose excess elicits hyperinsulinemia, which may derive, in the end, into insulin resistance. The available systems of energy disposal could not cope with the excess of substrates, since they are geared for saving not for spendthrift, which results in an unbearable overload of the storage mechanisms. Adipose tissue is the last energy sink, it has to store the energy that cannot be used otherwise. However, adipose tissue growth also has limits, and the excess of energy induces inflammation, helped by the ineffective intervention of the immune system. However, even under this acute situation, the excess of glucose remains, favoring its final conversion to fat. The sum of inflammatory signals and deranged substrate handling induce most of the metabolic syndrome traits: insulin resistance, obesity, diabetes, liver steatosis, hyperlipidemia and their compounded combined effects. Thus, a maintained excess of energy in the diet may result in difficulties in the disposal of glucose, eliciting inflammation and the development of the metabolic syndrome

Producció de biopolímers amb cultius bacterians mixtes. Comparació de tres reactors discontinus seqüencials (SBR) amb diferents condicions operacionals

La producció de biopolímers (polihidroxialcanoats (PHA) i substàncies polimèriques extracel·lulars (EPS)) a nivell industrial, resulta una nova àrea d’investigació que recull diverses disciplines, entre elles les Ciències Ambientals. Aquest projecte final de carrera amb el títol: “Producció de biopolímers amb cultius bacterians mixtes”, s’ha desenvolupat sota la supervisió de la directora de projecte Dra. María Eugenia Suárez Ojeda del Departament d’Enginyeria Química de la Universitat Autònoma de Barcelona (UAB) i s’ha dut a terme per l’estudiant Jordi Pérez i Forner de la Llicenciatura de Ciències Ambientals, Facultat de Ciències de la UAB, en el Departament d’Enginyeria Química de la mateixa universitat. L’objectiu d’aquest projecte ha estat produir biopolímers simultàniament amb l’eliminació de fòsfor i matèria orgànica en aigües residuals per obtenir un residu final amb un alt valor afegit. Aquests biopolímers reuneixen les característiques necessàries per a poder competir amb els plàstics convencionals i així, reduir l’elevat consum del petroli i la generació de residus no biodegradables. En aquest projecte s’ha dut a terme la posta en marxa d’un reactor discontinu seqüencial (SBR) per a l’acumulació de biopolímers amb cultius bacterians mixtes. Diferents investigadors han estudiat que aquests tipus de cultius bacterians arriben a nivells de fins el 53-97% [Pijuan et al., 2009] de contingut de biopolímers a la biomassa, sometent als microorganismes a diferents situacions d’estrés ja sigui per dèficit de nutrients o per variacions en les fases de feast-famine (festí-fam). Durant el projecte, s’ha realitzat el monitoratge del reactor alimentat amb una aigua sintètica, elaborada en el laboratori, amb les característiques d’un aigua residual provinent de la industria làctica. S’ha sotmès als microorganismes a diferents condicions operacionals, una d’elles amb limitació de fòsfor com a nutrient i una tercera condició amb una variació a les fases feast-famine. D’altra banda, com a segon objectiu, s’ha analitzat el contingut de biopolímers a la biomassa de dos SBRs més, del grup de recerca Bio-GLS del Departament d’Enginyeria Química de la UAB, alimentats amb diferents fonts de carboni, glicerol i àcids grassos de cadena llarga (AGCLL), per observar les influències que té el tipus de substrat en l’acumulació de biopolímers. Els resultats obtinguts en la primera part d’aquest projecte han estat similars als resultats d’altres investigadors [Pijuan et al., 2009; Guerrero et al., 2012]. S’ha determinat que sotmetre als microorganismes a situacions d’estrés té un efecte directe pel que fa a l’acumulació de biopolímers. També s’ha observat com al mateix temps que acumulaven aquests compostos, els microorganismes desenvolupaven la seva tasca de depurar l’aigua residual, obtenint al final del cicle una aigua amb un baix contingut en matèria orgànica i altres contaminants com amoni i fòsfor, en aquest cas. En la segona part del projecte, s’ha observat com el tipus de substrat té un efecte directe pel que fa a l’acumulació de biopolímers i també a l’activitat metabòlica dels microorganismes. Per tant, s’ha conclòs que la producció de biopolímers mitjançant la depuració d’aigües residuals es una via d’investigació molt prometedora pel que fa als resultats obtinguts. Alhora que es tracta un residu, s’obté una producte residual amb un alt valor afegit que pot ser utilitzat per la producció de bioplàstics 100% biodegradables.

Del plat al cervell

Per solucionar el sobrepés cal lluitar amb un model d'alimentació que és resultat de milions d'anys d'evolució instintiva i metabòlica

The metabolic syndrome, a multifaceted disease of affluence

Metabolic syndrome developed in consequence of an evolutionary inadequacy: the human body was unprepared for a dietary excess of nutrients, especially lipids (largely in detriment of carbohydrate). This excess awakens metabolic signals akin to those of starvation, in which the main energy staple is the body"s own lipid reserve. Lipid dietary abundance prevents the use of glucose, which in turn limits the oxidation of amino acids. To ward against a subsequent avalanche of substrates, the immune system and hypertrophied tissues (for example, adipose) elicit a series of defence responses. This response is probably the ultimate basis of a disease that is manifested as various pathologies, which were initially defined as distinct entities but which are slowly being seen as a single pathognomic unit in the literature. Based on their common origin of the ample availability of food in our modern society, the cluster of diseases comprising the metabolic syndrome is probably best described as a single multifaceted disease.

Metabolic alterations and increased liver mTOR expression precede the development of autoimmune disease in a murine model of lupus erythematosus

Although metabolic syndrome (MS) and systemic lupus erythematosus (SLE) are often associated, a common link has not been identified. Using the BWF1 mouse, which develops MS and SLE, we sought a molecular connection to explain the prevalence of these two diseases in the same individuals. We determined SLE- markers (plasma anti-ds-DNA antibodies, splenic regulatory T cells (Tregs) and cytokines, proteinuria and renal histology) and MS-markers (plasma glucose, non-esterified fatty acids, triglycerides, insulin and leptin, liver triglycerides, visceral adipose tissue, liver and adipose tissue expression of 86 insulin signaling-related genes) in 8-, 16-, 24-, and 36-week old BWF1 and control New-Zealand-White female mice. Up to week 16, BWF1 mice showed MS-markers (hyperleptinemia, hyperinsulinemia, fatty liver and visceral adipose tissue) that disappeared at week 36, when plasma anti-dsDNA antibodies, lupus nephritis and a pro-autoimmune cytokine profile were detected. BWF1 mice had hyperleptinemia and high splenic Tregs till week 16, thereby pointing to leptin resistance, as confirmed by the lack of increased liver P-Tyr-STAT-3. Hyperinsulinemia was associated with a down-regulation of insulin related-genes only in adipose tissue, whereas expression of liver mammalian target of rapamicyn (mTOR) was increased. Although leptin resistance presented early in BWF1 mice can slow-down the progression of autoimmunity, our results suggest that sustained insulin stimulation of organs, such as liver and probably kidneys, facilitates the over-expression and activity of mTOR and the development of SLE.

Altered nitrogen balance and decreased urea excretion in male rats fed cafeteria diet are related to arginine availability

Hyperlipidic diets limit glucose oxidation and favor amino acid preservation, hampering the elimination of excess dietary nitrogen and the catabolic utilization of amino acids.We analyzed whether reduced urea excretion was a consequence of higherNO ; (nitrite,nitrate, and other derivatives) availability caused by increased nitric oxide production in metabolic syndrome. Rats fed a cafeteria diet for 30 days had a higher intake and accumulation of amino acid nitrogen and lower urea excretion.There were no differences in plasma nitrate or nitrite. NO and creatinine excretion accounted for only a small part of total nitrogen excretion. Rats fed a cafeteria diet had higher plasma levels of glutamine, serine, threonine, glycine, and ornithinewhen comparedwith controls,whereas arginine was lower. Liver carbamoyl-phosphate synthetase I activity was higher in cafeteria diet-fed rats, but arginase I was lower. The high carbamoyl-phosphate synthetase activity and ornithine levels suggest activation of the urea cycle in cafeteria diet-fed rats, but low arginine levels point to a block in the urea cycle between ornithine and arginine, thereby preventing the elimination of excess nitrogen as urea. The ultimate consequence of this paradoxical block in the urea cycle seems to be the limitation of arginine production and/or availability.

The problem of nitrogen disposal in the obese

Amino-N is preserved because of the scarcity and nutritional importance of protein. Excretion requires its conversion to ammonia, later incorporated into urea. Under conditions of excess dietary energy, the body cannot easily dispose of the excess amino-N against the evolutively adapted schemes that prevent its wastage; thus ammonia and glutamine formation (and urea excretion) are decreased. High lipid (and energy) availability limits the utilisation of glucose, and high glucose spares the production of ammonium from amino acids, limiting the synthesis of glutamine and its utilisation by the intestine and kidney. The amino acid composition of the diet affects the production of ammonium depending on its composition and the individual amino acid catabolic pathways. Surplus amino acids enhance protein synthesis and growth, and the synthesis of non-protein-N-containing compounds. But these outlets are not enough; consequently, less-conventional mechanisms are activated, such as increased synthesis of NO∙ followed by higher nitrite (and nitrate) excretion and changes in the microbiota. There is also a significant production of N(2) gas, through unknown mechanisms. Health consequences of amino-N surplus are difficult to fathom because of the sparse data available, but it can be speculated that the effects may be negative, largely because the fundamental N homeostasis is stretched out of normalcy, forcing the N removal through pathways unprepared for that task. The unreliable results of hyperproteic diets, and part of the dysregulation found in the metabolic syndrome may be an unwanted consequence of this N disposal conflict.

Effects of a post-weaning cafeteria diet in young rats: metabolic syndrome, reduced activity and low anxiety-like behaviour.

Among adolescents, overweight, obesity and metabolic syndrome are rapidly increasing in recent years as a consequence of unhealthy palatable diets. Animal models of diet-induced obesity have been developed, but little is known about the behavioural patterns produced by the consumption of such diets. The aim of the present study was to determine the behavioural and biochemical effects of a cafeteria diet fed to juvenile male and female rats, as well as to evaluate the possible recovery from these effects by administering standard feeding during the last week of the study. Two groups of male and female rats were fed with either a standard chow diet (ST) or a cafeteria (CAF) diet from weaning and for 8 weeks. A third group of males (CAF withdrawal) was fed with the CAF diet for 7 weeks and the ST in the 8th week. Both males and females developed metabolic syndrome as a consequence of the CAF feeding, showing overweight, higher adiposity and liver weight, increased plasma levels of glucose, insulin and triglycerides, as well as insulin resistance, in comparison with their respective controls. The CAF diet reduced motor activity in all behavioural tests, enhanced exploration, reduced anxiety-like behaviour and increased social interaction; this last effect was more pronounced in females than in males. When compared to animals only fed with a CAF diet, CAF withdrawal increased anxiety in the open field, slightly decreased body weight, and completely recovered the liver weight, insulin sensitivity and the standard levels of glucose, insulin and triglycerides in plasma. In conclusion, a CAF diet fed to young animals for 8 weeks induced obesity and metabolic syndrome, and produced robust behavioural changes in young adult rats, whereas CAF withdrawal in the last week modestly increased anxiety, reversed the metabolic alterations and partially reduced overweight.

Método feldenkrais en el agua para el abordaje de la fatiga en deportistas no profesionales como prevención de la aparición de lesiones.

Este trabajo presenta un estudio comparativo de la técnica de movimiento consciente (Feldenkrais) aplicada en medio acuático con una técnica placebo. Su objetivo es la comprobación de la eficacia del entrenamiento Feldenkrais en susodicho medio para la disminución de sensaciones de fatiga, tanto aguda como muscular, y la mejora del rendimiento muscular para incidir en la reducción del número de lesiones. Se considera Una población de nadadores no profesionales con edades comprendidas entre los 18 y 35 años para realizar dicho estudio. Objetivo: Comprobar la eficacia del entrenamiento Feldenkrais en el agua en términos de sensación de fatiga y rendimiento muscular. Intervención: La población se dividirá en dos grupos: uno experimental al que se le aplicará la técnica Feldenkrais y otro de control o placebo. A su vez, cada grupo se dividirá en 5 subgrupos (uno para cada día de Lunes a Viernes). Se procederá con los ejercicios después de la sesión de entrenamiento y se tomarán cuatro mediciones (muestras) cada 3 semanas de: - respuesta metabólica con los niveles de ácido láctico y citoquinas. - respuesta de fatiga aguda. - respuesta de fatiga muscular. - co-contracción y relajación con electomiograma musculares. Las mediciones de la sensación de fatiga se realizarán mediante EIDF, escala de Borg modificada (escala revisada del esfuerzo percibido) e IMF. Los resultados se obtendrán mediante la comparación entre los dos grupos. Se tendrán en cuenta las medias obtenidas del análisis bivariado, correlaciones mediante la R de Pearson para las cuantitativas y la interpretación de la hipótesis (nula o alternativa).

El síndrome metabólico en el paciente renal

Se defi ne como síndrome metabólico al conjunto de factores que se dan en un individuo que le llevan a presentar resistencias a la insulina con hiperinsulinismo compensador que se asocia a trastornos del metabolismo hidrocarbonado, hipertensión arterial, alteraciones lipídicas y obesidad. Esta demostrado que este síndrome aumenta la posibilidad de padecer una enfermedad cardiovascular o diabetes mellitus por lo que se considera un factor de riesgo cardiovascular y de mortalidad en la población general. En pacientes...

Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?

The metabolic syndrome is basically a maturity-onset disease. Typically, its manifestations begin to flourish years after the initial dietary or environmental aggression began. Since most hormonal, metabolic, or defense responses are practically immediate, the procrastinated response do not seem justified. Only in childhood, the damages of the metabolic syndrome appear with minimal delay. Sex affects the incidence of the metabolic syndrome, but this is more an effect of timing than absolute gender differences, females holding better than males up to menopause, when the differences between sexes tend to disappear. The metabolic syndrome is related to an immune response, countered by a permanent increase in glucocorticoids, which keep the immune system at bay but also induce insulin resistance, alter the lipid metabolism, favor fat deposition, mobilize protein, and decrease androgen synthesis. Androgens limit the operation of glucocorticoids, which is also partly blocked by estrogens, since they decrease inflammation (which enhances glucocorticoid release). These facts suggest that the appearance of the metabolic syndrome symptoms depends on the strength (i.e., levels) of androgens and estrogens. The predominance of glucocorticoids and the full manifestation of the syndrome in men are favored by decreased androgen activity. Low androgens can be found in infancy, maturity, advanced age, or because of their inhibition by glucocorticoids (inflammation, stress, medical treatment). Estrogens decrease inflammation and reduce the glucocorticoid response. Low estrogen (infancy, menopause) again allow the predominance of glucocorticoids and the manifestation of the metabolic syndrome. It is postulated that the equilibrium between sex hormones and glucocorticoids may be a critical element in the timing of the manifestation of metabolic syndrome-related pathologies.

Steroid hormones interrelationships in the metabolic syndrome: an introduction to the ponderostat hypothesis

Sexual dimorphism in the metabolic syndrome. The clairvoyant early implication of sex hormones in the characterization of the metabolic syndrome (MS) was detected early, and in accordance with the well-known sex-related main patterns of fat deposition in obesity: gynoid and android. The differences point to a direct implication of androgens and estrogens in the development, properties and maintenance of obesity and, by extension, to the cumulus of diseases grouped in the MS. For a long time, the key issue of the MS, i.e. the metabolic event explaining (and justifying) most of the derangements of the MS, has been considered to be insulin resistance (...)

Autoevaluación: Fisiopatología del metabolismo

La respiración, la circulación sanguínea, la contracción de un músculo o el mero pensamiento son fenómenos que obligan a que nuestro organismo esté en constante cambio, produciendo y consumiendo energía. La palabra metabolismo deriva del griego metabolé y significa"cambio". Entendemos como metabolismo a todo el conjunto de reacciones bioquímicas y procesos físicos que ocurren en la célula y en el organismo. Todos estos procesos metabólicos tienen lugar en dos fases. Una fase, llamada anabolismo, en la que se consume energía para transformar moléculas pequeñas (como los aminoácidos) en moléculas mayores (proteínas), y otra fase, llamada catabolismo o fase destructiva, en la que moléculas mayores (glucógeno) se transforman en otras más pequeñas (ácido pirúvico) liberando energía en el proceso. Estos dos procesos son conjugados y cada uno depende del otro. Estas reacciones bioquímicas están organizadas de forma que se siga siempre una determinada ruta metabólica, de tal forma que un sustrato determinado es transformado en un producto concreto, y éste a su vez es el sustrato para crear otro producto. Dentro de esta vía existen unas proteínas llamadas enzimas que posibilitan estas reacciones, comportándose como factores reguladores de estas rutas metabólicas. El siguiente cuestionario tiene la finalidad de profundizar en algunos conceptos importantes dentro de la fisiopatología del metabolismo.

Verifique sus conocimientos sobre medicina nuclear (2): tomografía por emisión de positrones (PET) y PET con tomografía computerizada (PET-TC)

La presente entrega de la serie de Nursing sobre las pruebas complementarias está dedicada a la tomografía por emisión de positrones o PET, acrónimo de positron emission tomography. La PET es una técnica de diagnóstico por la imagen de medicina nuclear en la cual se administra al paciente un radiofármaco emisor de positrones. Este radiofármaco se incorpora a los tejidos adecuados siguiendo una vía metabólica determinada. La radiactividad emitida por esos tejidos del paciente es detectable por los equipos PET y se obtienen imágenes que proporcionan una información funcional in vivo. El radiofármaco PET más habitual es un análogo de la glucosa que se llama F-18-fluordesoxiglucosa, conocido como FDG, el cual permite estudiar la actividad metabólica. La incorporación de la tomografía computarizada (TC) en el mismo equipo híbrido PET-TC permite obtener además la información anatómica del paciente. En el presente artículo se describen los fundamentos físicos y fisiológicos básicos de las exploraciones PET-TC con FDG en oncología, así como los procedimientos de enfermería necesarios para el cuidado del paciente y la correcta obtención de las imágenes.

Verifique sus conocimientos sobre medicina nuclear (2): tomografía por emisión de positrones (PET) y PET con tomografía computerizada (PET-TC)

La presente entrega de la serie de Nursing sobre las pruebas complementarias está dedicada a la tomografía por emisión de positrones o PET, acrónimo de positron emission tomography. La PET es una técnica de diagnóstico por la imagen de medicina nuclear en la cual se administra al paciente un radiofármaco emisor de positrones. Este radiofármaco se incorpora a los tejidos adecuados siguiendo una vía metabólica determinada. La radiactividad emitida por esos tejidos del paciente es detectable por los equipos PET y se obtienen imágenes que proporcionan una información funcional in vivo. El radiofármaco PET más habitual es un análogo de la glucosa que se llama F-18-fluordesoxiglucosa, conocido como FDG, el cual permite estudiar la actividad metabólica. La incorporación de la tomografía computarizada (TC) en el mismo equipo híbrido PET-TC permite obtener además la información anatómica del paciente. En el presente artículo se describen los fundamentos físicos y fisiológicos básicos de las exploraciones PET-TC con FDG en oncología, así como los procedimientos de enfermería necesarios para el cuidado del paciente y la correcta obtención de las imágenes.